ISMIVS Newsletter May&June, 2022 Newsletter ISMIVS

ISMIVS Newsletter May&June, 2022

Newsletter 2022 May & June
2022年5&6月简报

About Us 国际微无创医学会简介

The International Society of Minimally Invasive and Virtual Surgery (ISMIVS, previously known as International Society of Minimally Invasive and Noninvasive Medicine) was founded in July 2013 at the gala of the 1st Yangtze International Summit of Minimally Invasive and Noninvasive Medicine in Chongqing, China. ISMIVS envisions to accelerating the progress in minimally invasive and noninvasive medicine by promoting research, education, communication, and international collaboration.
国际微无创医学会（ISMIVS）是在 2013 年 7 月在中国重庆召开的第一届国际微无创医学长江高峰论坛上宣布成立的，旨在通过学术研究、教育、交流以及国际合作加快微无创医学的发展。

Become a member 注册成为会员 >

The Personality in the Medical Education World 医学教育界的大人物

From the 2020 July issue of our ISMIVS Newsletter, we would like to introduce some pioneers in the field of minimally-invasive and noninvasive medicine. They are not only prestigious in their field but also willing to share their experience and ideas with younger doctors, hence making a great contribution to medical education. This issue features Dr Jordi Rodríguez González from Barcelona, who is engaged in the field of high intensity focused ultrasound (HIFU).
从 2020 年 7 月刊开始，国际微无创医学会将为大家介绍微无创医学领域的一些领军人物。他们不仅在各自的领域享负盛名，而且非常乐意与年轻医生分享他们的经验、理念和想法，从而为医学教育做出了巨大的贡献。本期月刊要介绍的是西班牙高强度聚焦超声（HIFU）领域的医学专家Jordi Rodríguez González医生。

Dr. Jordi Rodríguez González Head of HIFU Unit. Department of Obstetrics and Gynecology
Mútua Terrassa University Hospital,
Terrassa, Barcelona
Jordi Rodríguez González医生
西班牙特拉萨大学医院
妇产科HIFU治疗部门主任

President of the Benign Uterine Pathology Committee at the Mútua Terrassa University Hospital
Staff Member of the Functional Gynecologic-Oncology Unit at the Mútua Terrassa University Hospital
Peer Reviewer in International Journal of Hyperthermia
西班牙特拉萨大学医院良性子宫病学委员会主席
西班牙特拉萨大学医院妇科肿瘤功能科工作人员
国际热疗学杂志同行评审员

Dr Jordi Rodríguez González graduated in Medicine and Surgery from the Barcelona Central University (UB) in 1997, then specialized in Obstetrics and Gynecology at the Mútua Terrassa University Hospital, Barcelona, Spain from 2001 to 2005.
Jordi Rodríguez González 医生于 1997 年毕业于巴塞罗那中央大学，随后在西班牙巴塞罗那的特拉萨大学医院从事妇产科工作。
He was trained in the HIFU Training Base of China in 2009 and obtained certification in HIFU training in adenomyosis. With over 12 years of experience in HIFU clinical application, he is now the Head of HIFU Unit, Department of Obstetrics and Gynecology, in Mútua Terrassa University Hospital, treating nearly 1000 cases of gynecological disorders.
2009 年，他赴中国 HIFU 培训基地接受培训，并获得子宫腺肌症的 HIFU 培训证书。他拥有超过 12 年的 HIFU 临床应用经验，目前担任特拉萨大学医院妇产科 HIFU 科室的主任，治疗了近 1000 例妇科疾病。
He is also the Staff Member of the Functional Gynecologic-Oncology Unit President of the Benign Uterine Pathology Committee at the Mútua Terrassa University Hospital, Board Member of the ESGE-MESGE Working Group on Non-Surgical Ablative Therapy of Benign Uterine Disease, Collaborator at the International School of Gynecological Endoscopy (Igualada Hospital, Barcelona), and peer reviewer in several scientific journals (International Journal of Hyperthermia, Quantitative Imaging in Medicine and Surgery, Korean Journal of Radiology).
同时，他是 Parc Taulí 大学医院妇科肿瘤功能科的成员，特拉萨大学医院良性子宫病理学委员会主席，ESGE-MESGE 良性子宫疾病非手术消融疗法工作组成员，国际妇科内镜学院合作者，以及多个科学期刊（国际热疗杂志、医学和外科定量成像、韩国放射学杂志）的同行评审员。
Dr Jordi Rodríguez González is an excellent speaker who has been invited to various courses and congresses in gynecological endoscopic surgery and ultrasound therapy, both national and international.

Jordi Rodríguez González 医生也是一位优秀的演讲者，曾被邀请参加各种国内和国际的妇科内镜手术和超声治疗的课程与大型会议。

Watch his article and lecture on HIFU in the treatment of uterine fibroids:

点击查看Jordi医生在HIFU治疗子宫肌瘤方面的文章和讲座：

Pregnancy outcomes after ultrasound-guided high intensity focused ultrasound (USgHIFU) for conservative treatment of uterine fibroids: experience of a single institution

HIFU treatment for uterine fibroids and the pregnancy outcome

News 新闻

2022 APAGE-ISMIVS HIFU Series Webinars
Episode 1: Management of endometriosis, especially for patients with fertility desire
2022年国际微无创医学会（ISMIVS）与亚太妇产科内视镜暨微创治疗医学会（APAGE）联合会议
暨 2021 年高强度聚焦超声（HIFU）系列线上研讨会（AIH 2022）
第 1 期：HIFU治疗內异症，尤其针对有生育需求的病人

To continue the fascinating serial sessions of 2021 and also as a response to the cordial call from the global audience, the International Society of Minimally Invasive and Virtual Surgery (ISMIVS) and Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy (APAGE) initiate 2022 HIFU Series Webinars (AIH 2022) in May.
为延续 2021 年 HIFU 系列会议的热度与精彩，同时响应全球同僚的热切号召，国际微无创医学会（ISMIVS）和亚太妇产科内视镜暨微创治疗医学会（APAGE）于 2022 年 5 月正式启动新一年的 HIFU 系列研讨会（AIH 2022）。
AIH 2022 upgrades the program with hybrid session themes, which focuses on different gynecological diseases in 4 different episode, aiming to promote women’s health and preserve fertility through up-to-date scientific research, clinical practice and live demonstration from a line-up of world renowned physicians in the field of minimally invasive and noninvasive medicine.
AIH 2022 旨在带来四期多主题的复合型线上研讨会，邀请微无创医学领域的国际知名医学专家，通过最新的科学研究和临床实践聚焦四类不同的妇科疾病，共同促进全球妇女的健康和生育力。
The 1st episode of AIH 2022 “Management of endometriosis, especially for patients with fertility desire” kicked off on May 19th, with Dr Olarik Musigavong from Thailand and Dr Relly Yanuari Primariawan from Indonesia being the Session Chairs. Nearly 2000 audiences from 56 countries and regions joined this session online, making a strong start for AIH 2022.
首期研讨会“ HIFU 治疗內异症，尤其针对有生育需求的病人”于 5 月 19 日召开，由来自泰国的 Olarik Musigavong 医生和来自印度尼西亚的 Relly Yanuari Primariawan 医生担任会议主席。本期研讨会吸引了 56 个国家和地区近 2000 名观众线上参会，强势拉开了 AIH 2022 的帷幕。
Prof. Chyi-Long Lee, the Chairman of the Board of Trustees of APAGE, discussed the therapy for endometriosis in reproductive women. He first indicated that endometriosis was found in 10% of women in reproductive age and about 176 million women suffer from the disease worldwide, then he explained the mechanisms of mild or minimal endometriosis and infertility based on the paper and how deep endometriosis impacts fertility, based on which he introduced several surgical techniques including “A to Z” of DIE treatment. At the end of his lecture, he emphasized that laparoscopy should remain the gold standard whenever DE surgery is indicated and continuous training would always be the last puzzle for reproductive surgery.
APAGE 董事会主席李奇龙教授探讨了生殖期妇女子宫内膜异位症的治疗问题。他指出，约 10% 的育龄妇女患有子宫内膜异位症，全球约有 1.76 亿妇女患有此病。随后，他根据研究性论文解释了轻度或轻微子宫内膜异位症导致不孕不育的病理学机制，以及深层子宫内膜异位症影响生育的原因，并在此基础上介绍了数种治疗内膜异位症的手术技术，包括由“ A 到 Z ”的 DIE 治疗法。在讲座的最后，他强调，只要有 DE 手术的指征，腹腔镜手术仍应是治疗內异症的黄金标准，而坚持不懈的专业培训永远是精进生殖手术技巧的最终答案。
Prof. Lian Zhang, Secretary-General of ISMIVS, Director of Chongqing Haifu Hospital, compared ultrasound-guided HIFU (Usg-HIFU) and other surgical options for abdominal wall endometriosis (AWE). He first introduced the principle and indications of HIFU, showing some contrast enhanced MRIs of a patient with AWE before and after HIFU treatment. In addition, he indicated that there was no skin burn encountered, the pain did not recur during a mean follow-up of 18.7 months, and all treated nodules gradually shrank over time, then concluded that HIFU treatment was promising and could be used to treat AWE safely and the effectiveness of HIFU treatment for AWE was comparable with open surgery, with less adverse effects and short hospital stay.
ISMIVS秘书长、重庆海扶医院院长张练教授比较了超声引导下 HIFU（Usg-HIFU）治疗和其他手术方法治疗腹壁子宫内膜异位症（AWE）。他首先介绍了 HIFU 的原理和适应症，展示了一位 AWE 患者在 HIFU 治疗前后的对比增强MRI图像。此外，他表示在 HIFU 治疗 AWE 过程中，没有出现皮肤灼伤的不良反应，并且在平均 18.7 个月的随访中，疼痛没有复发，消融后的病灶随着时间的推移逐渐缩小。他总结说，HIFU 是一种很有前景的无创技术，可以安全地用于治疗 AWE，同时具有与开放手术相当的疗效，不良反应少，住院时间短。
Dr Min He, the Senior Training Lecturer, shared the learning curve of HIFU and her training experience in China, she indicated that basic requirements for clinicians to learn HIFU included specific medicine majors (ob-gyn, oncology, surgery, breast surgery, orthopaedics, medical imaging), image recognition ability (US/MRI), and understanding of HIFU. She also mentioned that factors affecting the learning curve of HIFU include ultrasonic image recognition ability, clinical experience, HIFU treatment related knowledge, number of cases and operation frequency. Since 2005, 2150 professionals have been trained in China’s HIFU training center.
HIFU 高级培训讲师何敏医生则分享了 HIFU 的学习曲线和她在中国的培训经验，她表示学习 HIFU 的临床医生需毕业于特定的医学专业（妇产科、肿瘤科、外科、乳腺外科、骨科、医学影像）、具备图像识别能力（US/MRI）和对 HIFU 的理解能力。她还提到，影响 HIFU 学习曲线的因素包括超声图像识别能力、临床经验、HIFU 治疗相关知识、病例数和手术频率。自 2005 年以来，中国的HIFU培训中心已经培训了 2150 名专业人员。

Watch the Playback >

查看会议回放 >

---------------

Episode 2: Treatment for Placenta Accreta and Cesarean Scar Pregnancy
第 2 期：胎盘植入与瘢痕妊娠的治疗

Themed “Treatment for Placenta Accreta and Cesarean Scar Pregnancy”, the 2nd episode of AIH 2022 opened on June 16th. Episode 2 invited Prof. Tsutsumi Osamu (Director of Sanno Hospital, Japan) and Prof. Chi-Chang Chang (President of Taiwan Association for Minimally Invasive Gynecology) to be the chairs, with 3 leading experts discussing minimally invasive and noninvasive therapies for patients with placenta accrete and cesarean scar pregnancy.
6 月 16 日，AIH 2022 第二期研讨会“胎盘植入与瘢痕妊娠的治疗”正式开讲。本期研讨会邀请到 Tsutsumi Osamu 教授（日本山王医院院长）和张基昌教授（台湾微创妇科协会会长）担任主席，联合 3 位国际权威专家探讨了针对胎盘植入与瘢痕妊娠患者的微无创治疗方法。
Prof. Aizura Adlan, Associate Professor of Department Obstetrics and Gynecology, University of Malaya, discussed the pathogenesis, diagnosis and management of placenta accreta and cesarean scar pregnancy (CSP). She believed that conservative management should be considered only for carefully selected cases of placenta accrete spectrum, cases that be considered investigational and after detailed counselling about the risks, uncertain benefits and efficacy. After demonstrating 4 cases of CSP, she provided several treatment modalities including laparoscopic caesarean scar resection, TAS-guided hysteroscopic curettage, and repeated HIFU combined with hysteroscopic S&C.
马来亚大学妇产科系副教授 Aizura Adlan 教授在会上讨论了胎盘植入和瘢痕妊娠（CSP）的发病机制、诊断和治疗。她认为，在应用保守治疗法之前，需审慎选择胎盘植入病例，确定其是否为研究性病例，并详细告知风险、潜在益处和疗效。此外，她分享了 4 个 CSP 病例，并提供了数种治疗方案，包括腹腔镜剖腹产疤痕切除术、TAS 引导下的宫腔镜刮宫术，以及多次 HIFU 结合宫腔镜吸刮术。
Dr Lee Jae Seong shared 13 years of clinical experience in the HIFU treatment for gynecological disorders at a single center in South Korea. From February 2010 to October 2017, his center managed 1807 cases (918 cases of uterine fibroids and 889 cases of adenomyosis), among which the uterine fibroid volume (mean ± SD) before HIFU is 176.46 ± 149.87, and 3 months and 12 months after HIFU is 79.87 ± 74.81 (55%) and 46.23 ± 54.7 (74%). He also provided clinical evidence for the safety and efficacy of HIFU therapy with several research papers, then end up summarizing that HIFU clinicians should be careful with patients who want future pregnancies and inform some possibilities of being in trouble of pregnancy and enough experience is needed to make satisfactory treatment outcomes.
李在星医生分享了他 13 年以来在韩国单中心应用HIFU治疗妇科疾病的临床经验。2010 年 2 月至 2017 年 10 月，他的中心共治疗了 1807 例妇科疾病患者（918 例子宫肌瘤和 889 例子宫腺肌症），其中 HIFU 治疗前的子宫肌瘤体积（平均值±标准差）为176.46±149.87，HIFU治疗后 3 个月和 12 个月分别为79.87±74.81（55%）和46.23±54.7（74%）。随后，他通过多篇研究论文为 HIFU 治疗的安全性和有效性提供了临床证据，并总结道，HIFU 临床医生应谨慎应对有生育需求的病人，告知病症对后期怀孕的影响，同时医生也需要积累足够的临床经验，才能获得满意的治疗效果。
Dr Zhang Cai, the Senior HIFU doctor, discussed clinical protocol and outcomes of HIFU followed by dilation and curettage to treat CSP. She first introduced the types of CSP based on the 2016 Chinese Expert Opinion and indicated that the aim of the management of CSP was to preserve fertility, and prevent life-threatening complications such as massive haemorrhage and uterine rupture. She further shared different sonication strategies of HIFU treatment for CSP and compared the adverse events, efficacy and fertility outcomes of HIFU and UAE, and concluded that HIFU therapy featured non-invasive and real-time monitoring qualities which could reduce the risk of vaginal massive bleeding, minimize damage to the uterine, and keep the fertility.
HIFU 高级医师张彩医师则探讨了 HIFU 治疗 CSP 的临床方案和结果。她首先根据《2016 年专家意见》介绍了三类CSP 分型，并指出治疗 CSP 的主要目的是保护生育能力，并且防止大量出血和子宫破裂等危及生命的并发症。她进一步分享了 HIFU 治疗 CSP 的不同超声策略，并比较了 HIFU 和 UAE 治疗 CSP 的不良事件、疗效和生育结果，认为 HIFU 治疗具有无创和实时监测的特点，可以降低阴道大量出血的风险，最大限度地减少对子宫的损伤，保持生育能力。

Watch the Playback >

查看会议回放 >

Notice 通知

The 3rd International Training Workshop on Focused Ultrasound Therapy For Tumors
"High Intensity Focused Ultrasound (HIFU) Therapy"
第 3 届聚焦超声无创治疗肿瘤技术国际培训班
"高强度聚焦超声(HIFU)治疗技术"

International Training Workshop on Focused Ultrasound Therapy for Tumors, a Chinese government sponsored medical training program, provides training courses on High Intensity Focused Ultrasound (HIFU) therapy for clinicians including obstetricians and gynecologists, oncologists, surgeons, interventional radiologists, etc. Since 2012, under the auspices of the Department of International Cooperation of the Ministry of Science and Technology of the People's Republic of China, it has been implemented for 7 sessions by Chongqing Medical University and ISMIVS jointly with different organizations, having trained 149 doctors from 42 countries. In 2018, this Workshop for the first time went abroad to Cairo, Egypt and continued its overseas education in Johannesburg, South Africa in 2019.
聚焦超声治疗肿瘤技术国际培训班是由中国政府出资启动的医疗培训项目，为妇产科、肿瘤科、外科、介入放射科等临床医生提供高强度聚焦超声（HIFU）治疗技术的培训课程。自 2012 年起，在中华人民共和国科技部国际合作司的支持下，重庆医科大学与国际微无创医学会联合各大组织机构成功开展 7 期培训项目，共计培养来自 42 个国家的 149 名医生。2018 年，该培训项目首次走向世界，于埃及开罗开办，并于 2019 年在南非约翰内斯堡继续开展海外培训。
The 2020 workshop which was planned to be held in Pleven, Bulgaria was postponed due to the COVID-19 Pandemic, now as the pandemic is better controlled, we plan to organize the 2022 Training Workshop in Malacca, Malaysia.
受疫情影响，原计划于保加利亚普列文举办的聚焦超声无创治疗肿瘤技术国际培训班因将在今年于马来西亚的马六甲举办。
For more information about the Workshop, please contact hannahxu@isminim.org
关于 2022 年国际培训班的更多信息，请联系 hannahxu@isminim.org

First Announcement >

----------------

APAGE-ISMIVS HIFU Series Webinars 2022
2021 年国际微无创医学会（ISMIVS）与亚太妇产科内视镜暨微创治疗医学会（APAGE）联合会议
暨 2021 年高强度聚焦超声（HIFU）系列线上研讨会（AIH）

APAGE and ISMIVS developed HIFU Series Webinars in 2020 to provide a platform where colleagues and beginners in the field of non-invasive and minimally invasive medicine can meet and exchange ideas. AIH is designed and delivered by renowned international experts with the latest research, clinical practice, and live demonstrations in terms of high intensity focused ultrasound, a sound and innovative technique for gynecologic diseases.
HIFU 系列线上研讨会由 APAGE 和 ISMIVS 于 2020 年发起，旨在搭建供微无创医学领域的同僚及初学者交流学习的平台，汇集全球知名专家，分享高强度聚焦超声（治疗妇科疾病的一种创新、无创技术）方面的最新研究、临床实践，以及手术过程演示。
AIH 2022 will see a fully hybrid program, combining the best features of our past programs with new topics and sessions.
AIH 2022 将带来多主题的复合型线上研讨会，融合往届精彩与全新主题，聚焦HIFU发展。
Topics at a glance: 会议主题预告：
- Management of endometriosis, especially patients with fertility desire
- Treatment for placenta accreta and cesarean scar pregnancy
- Treatment for vulva and cervical diseases-new options
- Adenomyosis and fertility
- HIFU 治疗內异症，尤其针对有生育需求的病人
- HIFU 治疗胎盘植入和瘢痕妊娠
- 治疗外阴和宫颈疾病的新选择
- 子宫腺肌症与生育

Episode 3
第 3 期

Date and Time: 18:00-19:50 (GMT+8) July 21, Thursday, 2022
Theme:Treatment for vulva and cervical diseases: new options
Free Registration:https://bit.ly/AIH2022EP3
日期与时间：2022 年 7 月 21 日（周四）18:00-19:55（北京时间）
主题：治疗外阴和宫颈疾病的新选择
注册链接：https://bit.ly/AIH2022EP3

More Events >

HIFU Special Issue 高强度聚焦超声特刊

We are delighted to announce that the International Journal of Hyperthermia, the HIFU Special Issue (i.e. Volume 38, 2021), which was partially supported by ISMIVS, was officially released in September. The Special Issue includes 15 articles written and reviewed by world-renowned scholars and pioneers in minimally invasive and noninvasive medicine, elaborating on the status and prospects of the clinical applications of high intensity focused ultrasound on tumours that occurred in specific organs. We'll share the 15 articles included in the upcoming newsletters, stay tuned!
我们很高兴地向大家宣布，由国际微无创医学会（ISMIVS）参与并大力支持的《国际热疗杂志：高强度聚焦超声（HIFU）特刊》已于九月正式发布。本期特刊邀请到多位微无创医学领域的国际知名专家和行业先驱参与编撰及审核，共包含15篇学术文章，阐述了高强度聚焦超声（HIFU）治疗人体各器官肿瘤的临床应用现状和发展前景。我们将陆续分享HIFU特刊中的文章，敬请期待！

Efficacy and safety of magnetic resonance-guided focused ultrasound treatment for refractory chronic pain of medial knee osteoarthritis
核磁引导下的聚焦超声治疗膝内侧骨关节炎难治性慢性疼痛的有效性和安全性

Totally twenty patients with medial knee OA eligible for total knee arthroplasty were included in this perspective. MRgFUS treatment was provided at the site of most severe tenderness around the medial femorotibial joint of each patient under real-time monitoring of temperature.
本次前瞻性研究共纳入 20 名符合全膝关节置换术条件的膝关节内侧 OA 患者。在实时监测温度的情况下，在每位患者的内侧股胫关节周围最严重的压痛部位提供 MRgFUS 治疗。
A 50% or greater decrease in NRS score was seen in 14 patients at 12 months post-treatment. The mean NRS score rapidly decreased 1 month after treatment and continued to decline through the following 12 months. No serious adverse events were observed during and after treatment.
在治疗后 12 个月时，14 名患者的 NRS 评分下降了 50% 或更多。平均 NRS 评分在治疗后 1 个月迅速下降，并在接下来的 12 个月持续下降。治疗期间和治疗后未观察到严重副作用。
MRgFUS treatments were effective not only for managing refractory pain but also for improving physical functions without adverse events in elderly patients with medial knee OA.
MRgFUS 治疗不仅对治疗难治性疼痛有效，而且对改善老年膝关节内侧 OA 患者的身体功能也无副作用。